BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Rigel Pharmaceuticals, Inc. (NQ: RIGL)
3.200 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 17, 2014  /  Add to My Watchlist      
(RIGL) Community Analysis from
Bulls REASONS TO BUY
Bears REASONS TO SELL
April 19, 2014
On July 23rd, Admiral Thad Allen said that the seep 3 kilometers from the leaking BP well was from the Rigel gas field: David Dishneau: Admiral, this is David Dishneau from The...(read more)
(Biotechnology Stock, 7/11/09)
On July 9th, Rigel Pharmaceuticals (RIGL) announced the results of TASKi2, a 457 patient Phase IIb Rheumatoid Arthritis study that in most part showed R788 ( a Syk kinase inhibitor)...(read more)
Here's a decent "high probability" covered call that came up in the scans tonight. RIGL is a pharmaceutical company that has some pending news on a rheumatoid arthritis drug so keep that in mind. With that...(read more)
Rigel Pharmaceuticals (RIGL) Company Overview

There is no analysis for RIGL yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here